Aino Soro‐Paavonen

3.6k total citations · 1 hit paper
30 papers, 2.5k citations indexed

About

Aino Soro‐Paavonen is a scholar working on Endocrinology, Diabetes and Metabolism, Cardiology and Cardiovascular Medicine and Clinical Biochemistry. According to data from OpenAlex, Aino Soro‐Paavonen has authored 30 papers receiving a total of 2.5k indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Endocrinology, Diabetes and Metabolism, 10 papers in Cardiology and Cardiovascular Medicine and 7 papers in Clinical Biochemistry. Recurrent topics in Aino Soro‐Paavonen's work include Diabetes, Cardiovascular Risks, and Lipoproteins (12 papers), Advanced Glycation End Products research (7 papers) and Cardiovascular Health and Disease Prevention (5 papers). Aino Soro‐Paavonen is often cited by papers focused on Diabetes, Cardiovascular Risks, and Lipoproteins (12 papers), Advanced Glycation End Products research (7 papers) and Cardiovascular Health and Disease Prevention (5 papers). Aino Soro‐Paavonen collaborates with scholars based in Finland, Australia and United States. Aino Soro‐Paavonen's co-authors include Marja‐Riitta Taskinen, Karin Jandeleit‐Dahm, Jukka Westerbacka, Merlin C. Thomas, Hannele Yki‐Järvinen, Martin Adiels, Muriel Caslake, Satu Vehkavaara, Jan Borén and Anna M.D. Watson and has published in prestigious journals such as Nature Genetics, The Journal of Clinical Endocrinology & Metabolism and Diabetes Care.

In The Last Decade

Aino Soro‐Paavonen

28 papers receiving 2.4k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Overproduction of large VLDL particles is driven by increased liver fat content in man

2006 537 citations Martin Adiels, Marja‐Riitta Taskinen et al. Diabetologia profile →

Peers

Countries citing papers authored by Aino Soro‐Paavonen

Since Specialization

Citations

This map shows the geographic impact of Aino Soro‐Paavonen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Aino Soro‐Paavonen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Aino Soro‐Paavonen more than expected).

Fields of papers citing papers by Aino Soro‐Paavonen

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Aino Soro‐Paavonen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Aino Soro‐Paavonen. The network helps show where Aino Soro‐Paavonen may publish in the future.

Co-authorship network of co-authors of Aino Soro‐Paavonen

This figure shows the co-authorship network connecting the top 25 collaborators of Aino Soro‐Paavonen. A scholar is included among the top collaborators of Aino Soro‐Paavonen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Aino Soro‐Paavonen. Aino Soro‐Paavonen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Insulin exposure mitigates the increase of arterial stiffness in patients with type 2 diabetes and albuminuria: an exploratory analysis 2019 ·Acta Diabetologica ·Daniel Gordin, Markku Saraheimo, (unknown), Aino Soro‐Paavonen, Carol Forsblom, Karri Paavonen, Birgit Steckel-Hamann, Valma Harjutsalo, (unknown), Imre Pávó, Veikko A Koivisto, Per‐Henrik Groop	6
2	Influence of Postprandial Hyperglycemic Conditions on Arterial Stiffness in Patients With Type 2 Diabetes 2016 ·The Journal of Clinical Endocrinology & Metabolism ·Daniel Gordin, Markku Saraheimo, (unknown), Aino Soro‐Paavonen, Carol Forsblom, Karri Paavonen, Birgit Steckel-Hamann, François Vandenhende, (unknown), Imre Pávó, Veikko A Koivisto, Per‐Henrik Groop	30
3	Oxygen deteriorates arterial function in type 1 diabetes 2015 ·Acta Diabetologica ·Daniel Gordin, Luciano Bernardi, Milla Rosengård‐Bärlund, (unknown), Aino Soro‐Paavonen, Carol Forsblom, (unknown), Per‐Henrik Groop	3
4	Alagebrium Reduces Glomerular Fibrogenesis and Inflammation Beyond Preventing RAGE Activation in Diabetic Apolipoprotein E Knockout Mice 2012 ·Diabetes ·Anna M.D. Watson, Stephen P. Gray, (unknown), Aino Soro‐Paavonen, (unknown), Mark E. Cooper, Angelika Bierhaus, R. J. Pickering, Christos Tikellis, Despina Tsorotes, Merlin C. Thomas, Karin Jandeleit‐Dahm	57
5	Circulating ACE2 activity is increased in patients with type 1 diabetes and vascular complications 2011 ·Journal of Hypertension ·Aino Soro‐Paavonen, Daniel Gordin, Carol Forsblom, Milla Rosengård‐Bärlund, Johan Wadén, Lena M. Thorn, Niina Sandholm, Merlin C. Thomas, Per‐Henrik Groop	161
6	Advanced glycation end-products induce vascular dysfunction via resistance to nitric oxide and suppression of endothelial nitric oxide synthase 2010 ·Journal of Hypertension ·Aino Soro‐Paavonen, (unknown), Kylie Venardos, Melinda T. Coughlan, (unknown), (unknown), Daniella Brasacchio, Karri Paavonen, Jaye Chin‐Dusting, Mark E. Cooper, David M. Kaye, Merlin C. Thomas, Josephine M. Forbes	88
7	Arterial stiffness and vascular complications in patients with type 1 diabetes: The Finnish Diabetic Nephropathy (FinnDiane) Study 2010 ·Annals of Medicine ·Daniel Gordin, Johan Wadén, Carol Forsblom, Lena M. Thorn, Milla Rosengård‐Bärlund, Outi Heikkilä, Markku Saraheimo, Nina Tolonen, Kustaa Hietala, Aino Soro‐Paavonen, (unknown), Ville‐Petteri Mäkinen, Tomi Peltola, Luciano Bernardi, Per‐Henrik Groop, (unknown)	31
8	Role of insulin as a negative regulator of plasma endocannabinoid levels in obese and nonobese subjects 2009 ·European Journal of Endocrinology ·Vincenzo Di Marzo, An Verrijken, Antti Hakkarainen, Stefania Petrosino, Ilse Mertens, Nina Lundbom, Fabiana Piscitelli, Jukka Westerbacka, Aino Soro‐Paavonen, Isabel Matias, Luc Van Gaal, Marja‐Riitta Taskinen	97
9	Angiotensin II subtype 2 receptor blockade and deficiency attenuate the development of atherosclerosis in an apolipoprotein E-deficient mouse model of diabetes 2009 ·Diabetologia ·Audrey Koı̈tka, Zemin Cao, Philip Koh, Anna M.D. Watson, (unknown), Laurent Loufrani, Aino Soro‐Paavonen, Thomas Walther, Kevin Woollard, Karin Jandeleit‐Dahm, M. E. Cooper, Terri J. Allen	30
10	THE AGE/RAGE AXIS IN DIABETES‐ACCELERATED ATHEROSCLEROSIS 2008 ·Clinical and Experimental Pharmacology and Physiology ·Karin Jandeleit‐Dahm, Anna M.D. Watson, Aino Soro‐Paavonen	62
11	Acute suppression of VLDL1 secretion rate by insulin is associated with hepatic fat content and insulin resistance 2007 ·Diabetologia ·Martin Adiels, Jukka Westerbacka, Aino Soro‐Paavonen, A.‐M. Häkkinen, Satu Vehkavaara, Muriel Caslake, C.J. Packard, S. Olofsson, Hannele Yki‐Järvinen, Marja‐Riitta Taskinen, Jan Borén	153
12	Common ABCA1 variants, HDL levels, and cellular cholesterol efflux in subjects with familial low HDL 2007 ·Journal of Lipid Research ·Aino Soro‐Paavonen, Jussi Naukkarinen, Miriam Lee‐Rueckert, Hiroshi Watanabe, Elina Rantala, Sanni Söderlund, Anne Hiukka, Petri T. Kovanen, Matti Jauhiainen, Leena Peltonen, Marja‐Riitta Taskinen	22
13	Overproduction of large VLDL particles is driven by increased liver fat content in man breakdown → 2006 ·Diabetologia ·Martin Adiels, Marja‐Riitta Taskinen, Chris J. Packard, Muriel Caslake, Aino Soro‐Paavonen, Jukka Westerbacka, Satu Vehkavaara, (unknown), S.‐O. Olofsson, Hannele Yki‐Järvinen, Jan Borén	537
14	ApoE Polymorphism Is Associated With C‐Reactive Protein in Low‐HDL Family Members and in Normolipidemic Subjects 2006 ·Mediators of Inflammation ·Juhani Kahri, Aino Soro‐Paavonen, Christian Ehnholm, Marja‐Riitta Taskinen	15
15	Novel Therapeutics for Diabetic Micro- and Macrovascular Complications 2006 ·Current Medicinal Chemistry ·Aino Soro‐Paavonen, Josephine M. Forbes	24
16	Hypertriglyceridemia is associated with preβ-HDL concentrations in subjects with familial low HDL 2005 ·Journal of Lipid Research ·Sanni Söderlund, Aino Soro‐Paavonen, Christian Ehnholm, Matti Jauhiainen, Marja‐Riitta Taskinen	24
17	Cross-species analyses implicate Lipin 1 involvement in human glucose metabolism 2005 ·Human Molecular Genetics ·Elina Suviolahti, Karen Reue, Rita M. Cantor, Jack Phan, Massimiliano Gentile, Jussi Naukkarinen, Aino Soro‐Paavonen, Laura Oksanen, Jaakko Kaprio, Aila Rissanen, Veikko Salomaa, Kimmo Kontula, Marja‐Riitta Taskinen, Päivi Pajukanta, Leena Peltonen	86
18	USF1 and dyslipidemias: converging evidence for a functional intronic variant 2005 ·Human Molecular Genetics ·Jussi Naukkarinen, Massimiliano Gentile, Aino Soro‐Paavonen, Janna Saarela, Heikki A. Koistinen, Päivi Pajukanta, Marja‐Riitta Taskinen, Leena Peltonen	70
19	Locus for quantitative HDL-cholesterol on chromosome 10q in Finnish families with dyslipidemia 2004 ·Journal of Lipid Research ·Heidi E. Lilja, Elina Suviolahti, Aino Soro‐Paavonen, Tero Hiekkalinna, (unknown), Kenneth Lange, Eric M. Sobel, Marja‐Riitta Taskinen, Leena Peltonen, Markus Perola, Päivi Pajukanta	23
20	Familial combined hyperlipidemia is associated with upstream transcription factor 1 (USF1) 2004 ·Nature Genetics ·Päivi Pajukanta, Heidi E. Lilja, Janet S. Sinsheimer, Rita M. Cantor, Aldons J. Lusis, Massimiliano Gentile, Xiaoqun Duan, Aino Soro‐Paavonen, Jussi Naukkarinen, Janna Saarela, Markku Laakso, Christian Ehnholm, Marja‐Riitta Taskinen, Leena Peltonen	252

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact